John Sarantopoulos
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Drug Discovery top 10%
Papers in
- Oncology 38
- Cancer Treatment and Pharmacology 10
- Colorectal Cancer Treatments and Studies 8
- Cancer Immunotherapy and Biomarkers 6
- Pharmacology 16
- Pharmacogenetics and Drug Metabolism 16
- Co-authors
- Devalingam Mahalingam (21 shared papers)Alain C. Mita (17 shared papers)Monica M Mita (15 shared papers)Anthony W. Tolcher (9 shared papers)Tyler Jay Curiel (3 shared papers)Francis Joseph Giles (4 shared papers)Chia‐Chi Lin (3 shared papers)Jordi A. Rodon (4 shared papers)
- Journals
- Cancer Chemotherapy and Pharmacology (17 papers)Clinical Cancer Research (14 papers)Investigational New Drugs (5 papers)Annals of Oncology (5 papers)Molecular Cancer Therapeutics (3 papers)
- Partner nations
- United StatesSwitzerlandSpain
In The Last Decade
John Sarantopoulos
80 papers receiving 3.9k citations
John Sarantopoulos's Hit Papers
Peers
Comparison fields: 5 of 86
- Oncology 1.1k
- Drug Discovery 6
- Biomaterials 248
- Pulmonary and Respiratory Medicine 556
- Genetics 147
Countries citing papers authored by John Sarantopoulos
This map shows the geographic impact of John Sarantopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Sarantopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Sarantopoulos more than expected).
Fields of papers citing papers by John Sarantopoulos
This network shows the impact of papers produced by John Sarantopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Sarantopoulos. The network helps show where John Sarantopoulos may publish in the future.
Co-authors
The 25 scholars most cited alongside John Sarantopoulos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 82 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial Hit paper breakdown → | 2020 | 367 |
| 2 | Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumors Hit paper breakdown → | 2021 | 299 |
| 3 | 2009 | 264 | |
| 4 | 2014 | 263 | |
| 5 | Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2022 | 212 |
| 6 | 2014 | 201 | |
| 7 | 2013 | 164 | |
| 8 | 2011 | 155 | |
| 9 | 2015 | 154 | |
| 10 | 2022 | 141 | |
| 11 | 2010 | 94 | |
| 12 | 2010 | 90 | |
| 13 | 2017 | 78 | |
| 14 | 2019 | 77 | |
| 15 | 2012 | 76 | |
| 16 | 2016 | 71 | |
| 17 | 2012 | 65 | |
| 18 | 2020 | 61 | |
| 19 | 2013 | 57 | |
| 20 | 2019 | 53 |
About John Sarantopoulos
John Sarantopoulos is a scholar working on Oncology, Pharmacology, Molecular Biology, Pulmonary and Respiratory Medicine and Statistics and Probability, having authored 82 papers that have together received 4k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (16 papers), Cancer Treatment and Pharmacology (10 papers), Colorectal Cancer Treatments and Studies (8 papers), Angiogenesis and VEGF in Cancer (7 papers), Lung Cancer Treatments and Mutations (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Statistical Methods in Clinical Trials (5 papers). The work is most often cited by research in Oncology (1.1k citations), Drug Discovery (6 citations), Biomaterials (248 citations), Pulmonary and Respiratory Medicine (556 citations) and Genetics (147 citations). John Sarantopoulos has collaborated with scholars based in United States, Switzerland and Spain. Frequent co-authors include Devalingam Mahalingam, Alain C. Mita, Monica M Mita, Anthony W. Tolcher, Tyler Jay Curiel, Francis Joseph Giles, Chia‐Chi Lin, Jordi A. Rodon, Kamalesh Kumar Sankhala and Leslie Wood. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Clinical Cancer Research, Investigational New Drugs, Annals of Oncology and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.